Centessa Pharmaceuticals(CNTA) - 2023 Q3 - Quarterly Report

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom (Address of principal executive offices and zip code) +44 7391 789784 Registrant's telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: | --- | --- | --- | |------ ...